<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">chemicallytech</journal-id><journal-title-group><journal-title xml:lang="en">Fine Chemical Technologies</journal-title><trans-title-group xml:lang="ru"><trans-title>Тонкие химические технологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-6593</issn><issn pub-type="epub">2686-7575</issn><publisher><publisher-name>MIREA – Russian Technological University (RTU MIREA).</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.32362/2410-6593-2020-15-6-16-33</article-id><article-id custom-type="elpub" pub-id-type="custom">chemicallytech-1664</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHEMISTRY AND TECHNOLOGY OF MEDICINAL COMPOUNDS AND BIOLOGICALLY ACTIVE SUBSTANCES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХИМИЯ И ТЕХНОЛОГИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ И БИОЛОГИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ</subject></subj-group></article-categories><title-group><article-title>Amino acid derivatives of natural chlorins as a platform for the creation of targeted photosensitizers in oncology</article-title><trans-title-group xml:lang="ru"><trans-title>Аминокислотные производные природных хлоринов как платформа для создания таргетных фотосенсибилизаторов в онкологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8353-1904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронов</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironov</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронов Андрей Федорович, доктор химических наук, профессор кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского; Scopus Author ID 55968884300</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Andrei F. Mironov, Dr. of Sci. (Chemistry), Professor, N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry; Scopus Author ID 55968884300</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">mironov_af@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5778-4510</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Островерхов</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostroverkhov</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Островерхов Петр Васильевич, аспирант, ассистент кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского; Scopus Author ID 57194061159</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Petr V. Ostroverkhov, Postgraduate Student, Assistant of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry; Scopus Author ID 57194061159</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">ostroverhov@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8262-3380</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихонов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tikhonov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тихонов Сергей Иванович, ассистент кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Sergei I. Tikhonov, Assistant of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">tihonov_s@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3556-8600</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Погорилый</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pogorilyy</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Погорилый Виктор Алексеевич, аспирант, ассистент кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского; Scopus Author ID 57201999616</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Viktor A. Pogorilyy, Postgraduate Student, Assistant of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry; Scopus Author ID 57201999616</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">pogorilyj@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9591-403X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирин</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirin</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кирин Никита Сергеевич, аспирант, ассистент кафедры химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского; Researcher ID ААА-7238-2020</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Nikita S. Kirin, Postgraduate Student, Assistant of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry; Researcher ID ААА-7238-2020</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">kirin@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3484-6613</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чудакова</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Chudakova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чудакова Ольга Олеговна, младший научный сотрудник; Reseacher ID Т-8560-2018</p><p>142290, Московская обл., г. Пущино, ул. Институтская, д. 2</p></bio><bio xml:lang="en"><p>Olga O. Chudakova, Junior Researcher; Reseacher ID Т-8560-2018</p><p>2, ul. Institutskaya, Pushchino, Moscow oblast, 142290</p></bio><email xlink:type="simple">chuda94@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2376-5658</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыганков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsygankov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цыганков Анатолий Анатольевич, доктор биологических наук, заведующий лабораторией биотехнологии и физиологии фототрофных организмов, директор; Scopus Author ID 7102020614, ResearcherID K-6541-2013</p><p>142290, Московская обл., г. Пущино, ул. Институтская, д. 2</p></bio><bio xml:lang="en"><p>Аnatolii А. Tsygankov, Dr. of Sci. (Biology), Head of the Laboratory of Biotechnology and Physiology of Phototrophic Organisms, Director; Scopus Author ID 7102020614, ResearcherID K-6541-2013</p><p>2, ul. Institutskaya, Pushchino, Moscow oblast, 142290</p></bio><email xlink:type="simple">ttt-00@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4333-4516</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grin</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Грин Михаил Александрович, доктор химических наук, профессор, заведующий кафедрой химии и технологии биологически активных соединений, медицинской и органической химии им. Н.А. Преображенского; Scopus Author ID 6603356480</p><p>119571, Москва, пр-т Вернадского, д. 86</p></bio><bio xml:lang="en"><p>Mikhail A. Grin, Dr. of Sci. (Chemistry), Professor, Head of the N.A. Preobrazhensky Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry; Scopus Author ID 6603356480</p><p>86, Vernadskogo pr., Moscow, 119571</p></bio><email xlink:type="simple">grin@mirea.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>МИРЭА – Российский технологический университет (Институт тонких химических технологий имени М.В. Ломоносова)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт фундаментальных проблем биологии, Российская академия наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Fundamental Problems of Biology, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>13</day><month>01</month><year>2021</year></pub-date><volume>15</volume><issue>6</issue><fpage>16</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Mironov A.F., Ostroverkhov P.V., Tikhonov S.I., Pogorilyy V.A., Kirin N.S., Chudakova O.O., Tsygankov A.A., Grin M.A., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Миронов А.Ф., Островерхов П.В., Тихонов С.И., Погорилый В.А., Кирин Н.С., Чудакова О.С., Цыганков А.А., Грин М.А.</copyright-holder><copyright-holder xml:lang="en">Mironov A.F., Ostroverkhov P.V., Tikhonov S.I., Pogorilyy V.A., Kirin N.S., Chudakova O.O., Tsygankov A.A., Grin M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.finechem-mirea.ru/jour/article/view/1664">https://www.finechem-mirea.ru/jour/article/view/1664</self-uri><abstract><sec><title>Objectives</title><p>Objectives. This study aims to obtain the amino acid derivatives of chlorophyll a and bacteriochlorophyll a for the targeted delivery of pigments to tumor foci. This will increase biocompatibility and, as a result, reduce toxic side effects. In addition to photodynamic efficiency, an additional cytotoxic effect is expected for the obtained conjugates of photosensitizers (PSs) with amino acids. This is owing to the participation of the latter in intracellular biochemical processes, including interaction with the components of the glutathione antioxidant system, leading to the vulnerability of tumor cells to oxidative stress.</p></sec><sec><title>Methods</title><p>Methods. In this work, we have implemented the optimization of the structure of a highly efficient infrared PS based on O-propyloxim-N-propoxybacteriopurpurinimide (DPBP), absorbing at 800 nm and showing photodynamic efficacy for the treatment of deep-seated and pigmented tumors, by introducing L-lysine, L-arginine, methionine sulfoximine (MSO), and buthionine sulfoximine (BSO) methyl esters. The structure of the obtained compounds was proved by mass spectrometry and nuclear magnetic resonance spectroscopy, and the photoinduced cytotoxicity was studied in vitro on the HeLa cell line.</p></sec><sec><title>Results</title><p>Results. Conjugates of DPBP with amino acids and their derivatives, such as lysine, arginine, MSO, and BSO have been prepared. The chelating ability of DPBP conjugate with lysine was shown, and its Sn(IV) complex was obtained.</p></sec><sec><title>Conclusions</title><p>Conclusions. Biological testing of DPBP with MSO and BSO showed a 5–6-fold increase in photoinduced cytotoxicity compared to the parent DPBP PS. Additionally, a high internalization of pigments by tumor cells was found, and the dark cytotoxicity (in the absence of irradiation) of DPBP-MSO and DPBP-BSO increased fourfold compared to the initial DPBP compound. This can be explained by the participation of methionine derivatives in the biochemical processes of the tumor cell.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цели</title><p>Цели. Целью настоящей работы является получение аминокислотных производных хлорофилла а и бактериохлорофилла а для направленной доставки пигментов в опухолевые очаги, увеличения биосовместимости и, как следствие, уменьшения побочного токсического действия. Кроме фотодинамической эффективности для полученных конъюгатов фотосенсибилизаторов с аминокислотами ожидается дополнительный цитотоксический эффект, вызванный участием последних во внутриклеточных биохимических процессах, включая взаимодействие с компонентами глутатионовой антиоксидантной системы, приводящее к уязвимости опухолевых клеток к окислительному стрессу.</p></sec><sec><title>Методы</title><p>Методы. В настоящей работе реализована оптимизация структуры высокоэффективного ИК-фотосенсибилизатора на основе О-пропилоксим-N-пропоксибактериопурпуринимида (DPBP), поглощающего при 800 нм и показавшего фотодинамическую эффективность для лечения глубокозалегающих и пигментированных опухолей, путем введения на периферию макроцикла метиловых эфиров L-лизина, L-аргинина, метионинсульфоксимина (MSO) и бутионинсульфоксимина (BSO). Структура полученных соединений доказана методами масс-спектрометрии и ЯМР-спектроскопии, а фотоиндуцированная цитотоксичность исследована in vitro на линии клеток HeLa.</p></sec><sec><title>Результаты</title><p>Результаты. Были получены конъюгаты О-пропилоксим-N-пропоксибактериопурпуринимида с аминокислотами и их производными, такими как, лизин, аргинин, метионинсульфоксимин и бутионинсульфоксимин. Показана хелатирующая способность конъюгата DPBP с лизином и получен его Sn(IV)-комплекс.</p></sec><sec><title>Выводы</title><p>Выводы. Биологические испытания DPBP с метионинсульфоксимином и бутионинсульфоксимином показали 5–6 кратное увеличение фотоиндуцированной цитотоксичности по сравнению с исходным фотосенсибилизатором DPBP. При этом обнаружена высокая интернализация пигментов опухолевыми клетками, а темновая цитотоксичность (при отсутствии облучения) DPBP-MSO и DPBP-BSO увеличилась в 4 раза по сравнению с исходным соединением DPBP, что может быть объяснено участием производных метионина в биохимических процессах опухолевой клетки.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хлорины</kwd><kwd>аминокислоты</kwd><kwd>бактериохлорины</kwd><kwd>фотосенсибилизаторы</kwd><kwd>фотодинамическая терапия</kwd><kwd>фотоиндуцированная цитотоксичность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chlorins</kwd><kwd>amino acids</kwd><kwd>bacteriochlorins</kwd><kwd>photosensitizers</kwd><kwd>photodynamic therapy</kwd><kwd>photo-induced cytotoxicity</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при финансовой поддержке РФФИ в рамках научного проекта № 19-33-90262 Аспиранты, а также это исследование было поддержано Министерством науки и высшего образования Российской Федерации (проект № 0706-2020-0019).</funding-statement><funding-statement xml:lang="en">The research was carried out with the financial support of the Russian Foundation for Basic Research within the framework of the scientific project No. 19-33-90262, and this study was supported by the Ministry of Science and Higher Education of the Russian Federation (project No. 0706-2020-0019). This article has been translated from Russian into English by H. Moshkov and edited for English language and spelling by Enago, an editing brand of Crimson Interactive Inc.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rakesh K.P., Darshini N., Manukumar H.M., Vivek H.K., Eissa M.Y.H., Prasanna D.S., Mallesha N. Xanthone. Conjugated аmino аcids as potential anticancer and DNA binding agents: molecular docking, cytotoxicity and SAR studies. Anticancer Agents Med. Chem. 2018;18(15):2169-2177. https://doi.org/10.2174/1871520618666180903105256</mixed-citation><mixed-citation xml:lang="en">Rakesh K.P., Darshini N., Manukumar H.M., Vivek H.K., Eissa M.Y.H., Prasanna D.S., Mallesha N. Xanthone. Conjugated аmino аcids as potential anticancer and DNA binding agents: molecular docking, cytotoxicity and SAR studies. Anticancer Agents Med. Chem. 2018;18(15):2169-2177. https://doi.org/10.2174/1871520618666180903105256</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sun J., Wei Q., Zhou Y., Wang J., Liu Q., Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Syst. Biol. 2017;11(s5):87. https://doi.org/10.1186/s12918-017-0464-7</mixed-citation><mixed-citation xml:lang="en">Sun J., Wei Q., Zhou Y., Wang J., Liu Q., Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Syst. Biol. 2017;11(s5):87. https://doi.org/10.1186/s12918-017-0464-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Girasolo M., Rubino S., Portanova P., Calvaruso G., Ruisi G., Stocco G. New organotin(IV) complexes with L-Arginine, Nα - t -Boc-L-Arginine and L-AlanylL-Arginine: Synthesis, structural investigations and cytotoxic activity. Journal of Organometallic Chemistry. 2010;695(4):609-618. https://doi.org/10.1016/j.jorganchem.2009.11.002</mixed-citation><mixed-citation xml:lang="en">Girasolo M., Rubino S., Portanova P., Calvaruso G., Ruisi G., Stocco G. New organotin(IV) complexes with L-Arginine, Nα - t -Boc-L-Arginine and L-AlanylL-Arginine: Synthesis, structural investigations and cytotoxic activity. Journal of Organometallic Chemistry. 2010;695(4):609-618. https://doi.org/10.1016/j.jorganchem.2009.11.002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mody T.D. Pharmaceutical development and medical applications of porphyrin-type macrocycles. J. Porphyr. Phthalocyanines. 2000;4(4):362-367. https://doi.org/10.1002/(SICI)1099-1409(200006/07)4:4%3C362::AID-JPP250%3E3.0.CO;2-Z</mixed-citation><mixed-citation xml:lang="en">Mody T.D. Pharmaceutical development and medical applications of porphyrin-type macrocycles. J. Porphyr. Phthalocyanines. 2000;4(4):362-367. https://doi.org/10.1002/(SICI)1099-1409(200006/07)4:4%3C362::AID-JPP250%3E3.0.CO;2-Z</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pandey R.K. Recent advances in photodynamic therapy. J. Porphyr. Phthalocyanines. 2000;4(4):368-373. https://doi.org/10.1002/(SICI)1099-1409(200006/07)4:4%3C368::AID-JPP244%3E3.0.CO;2-6</mixed-citation><mixed-citation xml:lang="en">Pandey R.K. Recent advances in photodynamic therapy. J. Porphyr. Phthalocyanines. 2000;4(4):368-373. https://doi.org/10.1002/(SICI)1099-1409(200006/07)4:4%3C368::AID-JPP244%3E3.0.CO;2-6</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng W., Zhao Y., Luo Q., Zhang Y., Wu K., Wang F. Multi-targeted anticancer agents. Curr. Top. Med. Chem. 2017;17:3084-3098. https://doi.org/10.2174/1568026617666170707124126</mixed-citation><mixed-citation xml:lang="en">Zheng W., Zhao Y., Luo Q., Zhang Y., Wu K., Wang F. Multi-targeted anticancer agents. Curr. Top. Med. Chem. 2017;17:3084-3098. https://doi.org/10.2174/1568026617666170707124126</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens M., Frobisher C., Hawkins M., Jenney M., Lancashire E., Reulen R., Taylor A., Winter D. The British childhood cancer survivor study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr. Blood Cancer. 2008;50:1018-1025. https://doi.org/10.1002/pbc.21335</mixed-citation><mixed-citation xml:lang="en">Stevens M., Frobisher C., Hawkins M., Jenney M., Lancashire E., Reulen R., Taylor A., Winter D. The British childhood cancer survivor study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr. Blood Cancer. 2008;50:1018-1025. https://doi.org/10.1002/pbc.21335</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">He R., Finan B., Mayer J.P., DiMarchi R.D. Peptide conjugates with small molecules designed to enhance efficacy and safety. Molecules. 2019;24:11-14. https://doi.org/10.3390/molecules24101855</mixed-citation><mixed-citation xml:lang="en">He R., Finan B., Mayer J.P., DiMarchi R.D. Peptide conjugates with small molecules designed to enhance efficacy and safety. Molecules. 2019;24:11-14. https://doi.org/10.3390/molecules24101855</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hoppenz P., Els-Heindl S., Beck-Sickinger A.G. Peptide-drug conjugates and their targets in advanced cancer therapies. Front. Chem. 2020;8:1-24. https://doi.org/10.3389/fchem.2020.00571</mixed-citation><mixed-citation xml:lang="en">Hoppenz P., Els-Heindl S., Beck-Sickinger A.G. Peptide-drug conjugates and their targets in advanced cancer therapies. Front. Chem. 2020;8:1-24. https://doi.org/10.3389/fchem.2020.00571</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Calvaresi E.C., Hergenrother P.J. Glucose conjugation for the specific targeting and treatment of cancer. Chem. Sci. 2013;4:2319-2333. https://doi.org/10.1039/c3sc22205e</mixed-citation><mixed-citation xml:lang="en">Calvaresi E.C., Hergenrother P.J. Glucose conjugation for the specific targeting and treatment of cancer. Chem. Sci. 2013;4:2319-2333. https://doi.org/10.1039/c3sc22205e</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hossain F., Andreana P.R. Developments in carbohydrate-based cancer therapeutics. Pharmaceuticals. 2019;12(2):84. https://doi.org/10.3390/ph12020084</mixed-citation><mixed-citation xml:lang="en">Hossain F., Andreana P.R. Developments in carbohydrate-based cancer therapeutics. Pharmaceuticals. 2019;12(2):84. https://doi.org/10.3390/ph12020084</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Posocco B., Dreussi E., De Santa J., Toffoli G., Abrami M., Musiani F., Grassi M., Farra R., Tonon F., Grassi G., Dapas B. Polysaccharides for the delivery of antitumor drugs. Materials (Basel). 2015;8(5):2569-2615. https://doi.org/10.3390/ma8052569</mixed-citation><mixed-citation xml:lang="en">Posocco B., Dreussi E., De Santa J., Toffoli G., Abrami M., Musiani F., Grassi M., Farra R., Tonon F., Grassi G., Dapas B. Polysaccharides for the delivery of antitumor drugs. Materials (Basel). 2015;8(5):2569-2615. https://doi.org/10.3390/ma8052569</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Sui C., Yang W., Luo Q. Amino acid transporters: Emerging roles in drug delivery for tumortargeting therapy. Asian J. Pharm. Sci. 2020;15(2):192-206. https://doi.org/10.1016/j.ajps.2019.12.002</mixed-citation><mixed-citation xml:lang="en">Zhang L., Sui C., Yang W., Luo Q. Amino acid transporters: Emerging roles in drug delivery for tumortargeting therapy. Asian J. Pharm. Sci. 2020;15(2):192-206. https://doi.org/10.1016/j.ajps.2019.12.002</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lu Y., Wang W., Wang J., Yang C., Mao H., Fu X., Wu Y., Cai J., Han J., Xu Z., Zhuang Z., Liu Z., Hu H., Chen B. Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue. PLoS One. 2013;8(9):1-8. https://doi.org/10.1371/journal.pone.0073866</mixed-citation><mixed-citation xml:lang="en">Lu Y., Wang W., Wang J., Yang C., Mao H., Fu X., Wu Y., Cai J., Han J., Xu Z., Zhuang Z., Liu Z., Hu H., Chen B. Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue. PLoS One. 2013;8(9):1-8. https://doi.org/10.1371/journal.pone.0073866</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Facon T., Mary J.Y., Hulin C., Benboubker L., Attal M., Pegourie B., Renaud M., Harousseau J.L., Guillerm G., Chaleteix C., Dib M., Voillat L., Maisonneuve H., Troncy J., Dorvaux V., Monconduit M., Martin C., Casassus P., Jaubert J., Jardel H., Doyen C., Kolb B., Anglaret B., Grosbois B., Yakoub-Agha I., Mathiot C., Avet-Loiseau H. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet. 2007;370(9594):1209-18. https://doi.org/10.1016/S0140-6736(07)61537-2</mixed-citation><mixed-citation xml:lang="en">Facon T., Mary J.Y., Hulin C., Benboubker L., Attal M., Pegourie B., Renaud M., Harousseau J.L., Guillerm G., Chaleteix C., Dib M., Voillat L., Maisonneuve H., Troncy J., Dorvaux V., Monconduit M., Martin C., Casassus P., Jaubert J., Jardel H., Doyen C., Kolb B., Anglaret B., Grosbois B., Yakoub-Agha I., Mathiot C., Avet-Loiseau H. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet. 2007;370(9594):1209-18. https://doi.org/10.1016/S0140-6736(07)61537-2</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Spanswick V.J., Lowe H.L., Newton C., Bingham J.P., Bagnobianchi A., Kiakos K., Craddock C., Ledermann J.A., Hochhauser D., Hartley J.A. Evidence for different mechanisms of “unhooking” for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples. BMC Cancer. 2012;12(1):1-13. https://doi.org/10.1186/1471-2407-12-436</mixed-citation><mixed-citation xml:lang="en">Spanswick V.J., Lowe H.L., Newton C., Bingham J.P., Bagnobianchi A., Kiakos K., Craddock C., Ledermann J.A., Hochhauser D., Hartley J.A. Evidence for different mechanisms of “unhooking” for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples. BMC Cancer. 2012;12(1):1-13. https://doi.org/10.1186/1471-2407-12-436</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Baker A., Kanofsky J.R., Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochem. Photobiol. 1992;55(4):523-8. https://doi.org/10.1111/j.1751-1097.1992.tb04273.x</mixed-citation><mixed-citation xml:lang="en">Baker A., Kanofsky J.R., Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochem. Photobiol. 1992;55(4):523-8. https://doi.org/10.1111/j.1751-1097.1992.tb04273.x</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. B Biol. 1990;6(3):343-347. https://doi.org/10.1016/1011-1344(90)85104-5</mixed-citation><mixed-citation xml:lang="en">Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. B Biol. 1990;6(3):343-347. https://doi.org/10.1016/1011-1344(90)85104-5</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grin M., Mironov A., Shtil A. Bacteriochlorophyll a and its derivatives: chemistry and perspectives for cancer therapy. Anticancer. Agents Med. Chem. 2012;8(6):683-697. https://doi.org/10.2174/1871520610808060683</mixed-citation><mixed-citation xml:lang="en">Grin M., Mironov A., Shtil A. Bacteriochlorophyll a and its derivatives: chemistry and perspectives for cancer therapy. Anticancer. Agents Med. Chem. 2012;8(6):683-697. https://doi.org/10.2174/1871520610808060683</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mironov A.F., Grin M.A., Pantushenko I.V., Ostroverkhov P.V., Ivanenkov Y.A., Filkov G.I., Plotnikova E.A., Karmakova T.A., Starovoitova A.V., Burmistrova N.V., Yuzhakov V.V., Romanko Y.S., Abakumov M.A., Ignatova A.A., Feofanov A.V., Kaplan M.A., Yakubovskaya R.I., Tsigankov A.A., Majouga A.G. Synthesis and Investigation of photophysical and biological properties of novel s-containing bacteriopurpurinimides. J. Med. Chem. 2017;60(24):10220-10230. https://doi.org/10.1021/acs.jmedchem.7b00577</mixed-citation><mixed-citation xml:lang="en">Mironov A.F., Grin M.A., Pantushenko I.V., Ostroverkhov P.V., Ivanenkov Y.A., Filkov G.I., Plotnikova E.A., Karmakova T.A., Starovoitova A.V., Burmistrova N.V., Yuzhakov V.V., Romanko Y.S., Abakumov M.A., Ignatova A.A., Feofanov A.V., Kaplan M.A., Yakubovskaya R.I., Tsigankov A.A., Majouga A.G. Synthesis and Investigation of photophysical and biological properties of novel s-containing bacteriopurpurinimides. J. Med. Chem. 2017;60(24):10220-10230. https://doi.org/10.1021/acs.jmedchem.7b00577</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kessel D. Subcellular targets for photodynamic therapy: Implications for initiation of apoptosis and autophagy. J. Natl. Compr. Cancer Netw. 2012;2(02):56-59. https://doi.org/10.6004/jnccn.2012.0177</mixed-citation><mixed-citation xml:lang="en">Kessel D. Subcellular targets for photodynamic therapy: Implications for initiation of apoptosis and autophagy. J. Natl. Compr. Cancer Netw. 2012;2(02):56-59. https://doi.org/10.6004/jnccn.2012.0177</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kang J.H., Ko Y.T. Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors. Biomater. Sci. 2019;7(7):2812-2825. https://doi.org/10.1039/c9bm00403c</mixed-citation><mixed-citation xml:lang="en">Kang J.H., Ko Y.T. Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors. Biomater. Sci. 2019;7(7):2812-2825. https://doi.org/10.1039/c9bm00403c</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan J., Oseroff A.R. Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. Rev. 2001;49(1-2):71-86. https://doi.org/10.1016/S0169-409X(01)00126-0</mixed-citation><mixed-citation xml:lang="en">Morgan J., Oseroff A.R. Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. Rev. 2001;49(1-2):71-86. https://doi.org/10.1016/S0169-409X(01)00126-0</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas A.P., Palanikumar L., Jeena M.T., Kim K., Ryu J.H. Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye. Chem. Sci. 2017;8:8351-8356. https://doi.org/10.1039/c7sc03169f</mixed-citation><mixed-citation xml:lang="en">Thomas A.P., Palanikumar L., Jeena M.T., Kim K., Ryu J.H. Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye. Chem. Sci. 2017;8:8351-8356. https://doi.org/10.1039/c7sc03169f</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mahalingam S.M., Ordaz J.D., Low P.S. Targeting of a photosensitizer to the mitochondrion enhances the potency of photodynamic therapy. ACS Omega. 2018;3(6): 6066-6074. https://doi.org/10.1021/acsomega.8b00692</mixed-citation><mixed-citation xml:lang="en">Mahalingam S.M., Ordaz J.D., Low P.S. Targeting of a photosensitizer to the mitochondrion enhances the potency of photodynamic therapy. ACS Omega. 2018;3(6): 6066-6074. https://doi.org/10.1021/acsomega.8b00692</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenbach-Belkin V., Chen L., Fiedor L., Tregub I., Pavlotsky F., Brumfeld V., Salomon Y., Scherz A. Serine conjugates of chlorophyll and bacteriochlorophyll: Photocytotoxicity in vitro and tissue distribution in mice bearing melanoma tumors. Photochem. Photobiol. 1996;64(1):174-181. https://doi.org/10.1111/j.1751-1097.1996.tb02439.x</mixed-citation><mixed-citation xml:lang="en">Rosenbach-Belkin V., Chen L., Fiedor L., Tregub I., Pavlotsky F., Brumfeld V., Salomon Y., Scherz A. Serine conjugates of chlorophyll and bacteriochlorophyll: Photocytotoxicity in vitro and tissue distribution in mice bearing melanoma tumors. Photochem. Photobiol. 1996;64(1):174-181. https://doi.org/10.1111/j.1751-1097.1996.tb02439.x</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Brandis A.S., Salomon Y., Scherz A. Chlorophyll Sensitizers in Photodynamic Therapy. In: Grimm B., Porra R.J., Rüdiger W., Scheer H. (eds). Chlorophylls and Bacteriochlorophylls. Advances in Photosynthesis and Respiration, vol 25. Dordrecht: Springer, 2006, 461-483. https://doi.org/10.1007/1-4020-4516-6_32</mixed-citation><mixed-citation xml:lang="en">Brandis A.S., Salomon Y., Scherz A. Chlorophyll Sensitizers in Photodynamic Therapy. In: Grimm B., Porra R.J., Rüdiger W., Scheer H. (eds). Chlorophylls and Bacteriochlorophylls. Advances in Photosynthesis and Respiration, vol 25. Dordrecht: Springer, 2006, 461-483. https://doi.org/10.1007/1-4020-4516-6_32</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Hargus J., Fronczek F., Vicente M., Smith K. Mono-(L)-aspartylchlorine-e6 . Photochemistry and Photobiology. 2007;83:1006-1015. https://doi.org/10.1111/j.1751-1097.2007.00092.x</mixed-citation><mixed-citation xml:lang="en">Hargus J., Fronczek F., Vicente M., Smith K. Mono-(L)-aspartylchlorine-e6 . Photochemistry and Photobiology. 2007;83:1006-1015. https://doi.org/10.1111/j.1751-1097.2007.00092.x</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Jinadasa R.G.W., Hu X., Grac M., Vicente H., Smith K.M. Syntheses and cellular investigations of 173 -, 152 -, and 131 -amino acid derivatives of chlorin e6. J. Med. Chem. 2011;54(21):7464-7476. https://doi.org/10.1021/jm2005139</mixed-citation><mixed-citation xml:lang="en">Jinadasa R.G.W., Hu X., Grac M., Vicente H., Smith K.M. Syntheses and cellular investigations of 173 -, 152 -, and 131 -amino acid derivatives of chlorin e6. J. Med. Chem. 2011;54(21):7464-7476. https://doi.org/10.1021/jm2005139</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Serra V.V., Zamarron A., Faustino M.A.F., La Cruz M.C.I.D., Blázquez A., Rodrigues J.M.M., Neves M.G.P.M.S., Cavaleiro J.A.S., Juarranz A., Sanz-Rodríguez F. New porphyrin amino acid conjugates: Synthesis and photodynamic effect in human epithelial cells. Bioorganic Med. Chem. 2010;18(16):6170-6178.</mixed-citation><mixed-citation xml:lang="en">Serra V.V., Zamarron A., Faustino M.A.F., La Cruz M.C.I.D., Blázquez A., Rodrigues J.M.M., Neves M.G.P.M.S., Cavaleiro J.A.S., Juarranz A., Sanz-Rodríguez F. New porphyrin amino acid conjugates: Synthesis and photodynamic effect in human epithelial cells. Bioorganic Med. Chem. 2010;18(16):6170-6178.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Wang A., Zhou R., Zhou L., Sun K., Jiang J., Wei S. Positively charged phthalocyanine-arginine conjugates as efficient photosensitizer for photodynamic therapy. Bioorganic Med. Chem. 2017;25(17):1643-1651. https://doi.org/10.1016/j.bmc.2017.01.029</mixed-citation><mixed-citation xml:lang="en">Wang A., Zhou R., Zhou L., Sun K., Jiang J., Wei S. Positively charged phthalocyanine-arginine conjugates as efficient photosensitizer for photodynamic therapy. Bioorganic Med. Chem. 2017;25(17):1643-1651. https://doi.org/10.1016/j.bmc.2017.01.029</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Meng S., Xu Z., Hong G., Zhao L., Zhao Z., Guo J., Ji H., Liu T. Synthesis, Characterization and in Vitro Photodynamic Antimicrobial Activity of Basic Amino AcidPorphyrin Conjugates. European Journal of Medicinal Chemistry. 2015;92:35-48. https://doi.org/10.1016/j.ejmech.2014.12.029</mixed-citation><mixed-citation xml:lang="en">Meng S., Xu Z., Hong G., Zhao L., Zhao Z., Guo J., Ji H., Liu T. Synthesis, Characterization and in Vitro Photodynamic Antimicrobial Activity of Basic Amino AcidPorphyrin Conjugates. European Journal of Medicinal Chemistry. 2015;92:35-48. https://doi.org/10.1016/j.ejmech.2014.12.029</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Lu S.C. Regulation of glutathione synthesis. Mol. Aspects Med. 2009;30(1-2):42-59. https://doi.org/10.1016/j.mam.2008.05.005</mixed-citation><mixed-citation xml:lang="en">Lu S.C. Regulation of glutathione synthesis. Mol. Aspects Med. 2009;30(1-2):42-59. https://doi.org/10.1016/j.mam.2008.05.005</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Singh S., Khan A.R., Gupta A.K. Role of glutathione in cancer pathophysiology and therapeutic interventions. J. Exp. Ther. Oncol. 2012;9(4):303-16.</mixed-citation><mixed-citation xml:lang="en">Singh S., Khan A.R., Gupta A.K. Role of glutathione in cancer pathophysiology and therapeutic interventions. J. Exp. Ther. Oncol. 2012;9(4):303-16.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Grin M.A., Pogorilyy V.A., Noev A.N., Tikhonov S.I., Majouga A.G., Mironov A.F. Bacteriochlorophyll a derivatives with sulfur-containing amino acids as promising photosensitizers for cancer PDT. Macroheterocycles. 2018;11:89-94. https://doi.org/10.6060/mhc180176p</mixed-citation><mixed-citation xml:lang="en">Grin M.A., Pogorilyy V.A., Noev A.N., Tikhonov S.I., Majouga A.G., Mironov A.F. Bacteriochlorophyll a derivatives with sulfur-containing amino acids as promising photosensitizers for cancer PDT. Macroheterocycles. 2018;11:89-94. https://doi.org/10.6060/mhc180176p</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Gielen M. Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels. Applied Organometallic Chemistry. 2002;16(9):481-494. https://doi.org/10.1002/aoc.331</mixed-citation><mixed-citation xml:lang="en">Gielen M. Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels. Applied Organometallic Chemistry. 2002;16(9):481-494. https://doi.org/10.1002/aoc.331</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Gielen M. Tin-based antitumour drugs. Coordination Chemistry Reviews. 1996;151:41-51. https://doi.org/10.1016/S0010-8545(96)90193-9</mixed-citation><mixed-citation xml:lang="en">Gielen M. Tin-based antitumour drugs. Coordination Chemistry Reviews. 1996;151:41-51. https://doi.org/10.1016/S0010-8545(96)90193-9</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gielen M., Biesemans M., Willem R. Organotin compounds: from kinetics to stereochemistry and antitumour activities. Applied organometallic chemistry. 2005;19(4):440-450. https://doi.org/10.1002/aoc.771</mixed-citation><mixed-citation xml:lang="en">Gielen M., Biesemans M., Willem R. Organotin compounds: from kinetics to stereochemistry and antitumour activities. Applied organometallic chemistry. 2005;19(4):440-450. https://doi.org/10.1002/aoc.771</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bregadze V.I., Glazun S.A. Metal-containing carboranes with antitumor activity. Russian Chemical Bulletin. 2007;56(4):643-659.</mixed-citation><mixed-citation xml:lang="en">Bregadze V.I., Glazun S.A. Metal-containing carboranes with antitumor activity. Russian Chemical Bulletin. 2007;56(4):643-659.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Montero D., Tachibana C., Rahr Winther J., Appenzeller-Herzog C., Intracellular glutathione pools are heterogeneously concentrated. Redox Biol. 2013;1(1):508-513. https://doi.org/10.1016/j.redox.2013.10.005</mixed-citation><mixed-citation xml:lang="en">Montero D., Tachibana C., Rahr Winther J., Appenzeller-Herzog C., Intracellular glutathione pools are heterogeneously concentrated. Redox Biol. 2013;1(1):508-513. https://doi.org/10.1016/j.redox.2013.10.005</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
